{
    "2019-10-09": [
        [
            {
                "time": "",
                "original_text": "康泰生物：前三季度盈利预增10.31%—16.96%",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "盈利预增",
                        "前三季"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物(300601.SZ)第三季度净利润预增74.58%-102.41%",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "净利润预增",
                        "第三季度"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：前三季净预增10%-17%",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "净预增",
                        "前三季"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：预计前三季净利同比增长10.31%-16.96%",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "净利增长",
                        "前三季"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【医药-康泰生物(300601)】江琦、赵磊：2019Q3预告点评：四联苗和23价肺炎疫苗双轮驱动，业绩恢复增长-1010",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "四联苗",
                        "23价肺炎疫苗",
                        "业绩恢复增长",
                        "2019Q3"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}